Category: <span>Dr. Roy Herbst</span>

Category: Dr. Roy Herbst

Bristol-Myers Squibb, Dr. Richard Pazdur, Dr. Roy Herbst, Dr. Scott Gettinger, FDA, Immunotherapy, Keytruda, Merck, mesothelioma, Mesothelioma News, Mesothelioma treatment, Opdivo

Can Opdivo Drug Be Good News for Mesothelioma Patients?

 

Expanded approved use of new lung cancer drug Opdivo could give malignant pleural mesothelioma patients hope.